Clinical Trial Update: Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab for efficacy and safety in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED